Filter by
Filter by
Treatment Tolerability and Toxicity of Postoperative Proton Beam Therapy for Gynecologic Malignancies: Results of the Prospective Phase 2 APROVE Trial.
This study by the Heidelberg group reported clinical outcomes of 25 patients with uterine cervical or endometrial cancer treated with postoperative PBT. Proton...
If we build it, will they come? Modeling of public hospital care requirements for the Australian Bragg Centre for Proton Therapy and Research.
This is a model estimation for patient capacity of The Australian Bragg Centre for Proton Therapy and Research (ABCPTR), which is the first proton facility in...
An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia.
Published in the Green Journal, this report aimed to establish treatment indications and potential patient numbers for carbon ion radiation therapy (CIRT) at...
DynamicARC® – Overview
IBA is developing a novel proton therapy delivery technique called DynamicARC®. This technique allows dynamic irradiation while the gantry is rotating. It...
ConformalFLASH® - Overview
ConformalFLASH combines the biological tissue sparing effects of FLASH with physics sparing effects of Proton Bragg Peak.
IBA is investing heavily in...
Motion Management – Overview
Today, 25% of patients that could benefit from proton therapy have moving tumors. However, as treating moving targets with confidence is a challenge, only 1% of...
The inevitability of Proton Therapy: Embracing Proton Therapy for Future-Proof Radiotherapy
This IBA Power Up event serves as an essential platform for radiotherapy departments to discover, learn about, and embrace the power of proton therapy. Our...